American Medical Technologies, Inc. (Nasdaq:ADLI) announced that it has received 510(k) FDA clearance to market its new CaviLase(TM) Erbium:YAG hard tissue dental laser.
"We think this is great news for the company and for dentists. Hard tissue lasers have come of age, and we believe that we have the best product available," said Ben J. Gallant, Chairman and Chief Executive Officer. "Our new CaviLase(TM) represents the best all-purpose laser for dentistry with breakthrough technology for ease of use and patient comfort. It is also the first affordable hard tissue laser. For most dentists, spending $40,000 or nearly $50,000 for the lasers currently on the market is out of the question."
The CaviLase(TM) Erbium:YAG Dental Laser is cleared for all classes of cavity preparations and most treatments can be done without anesthesia. The CaviLase(TM) uses advanced variable pulsewidth technology to produce long pulses for hard tissue, and short pulses, with acknowledged benefits, for soft tissue. This technology also allows the CaviLase(TM) to have double the pulse rate of existing erbium units for smoother, better soft tissue cutting. Powerful handpiece illumination, common to air driven dental handpieces, is available on the CaviLase(TM) -- a first for dental lasers. Six user adjustable pre-sets give the dentist full control of energy/pulse, pulse rate, and water and air setting.
"Sales of hard tissue lasers have been increasing rapidly, and we like our prospects with the CaviLase(TM) very much," said Gallant. "We will have significant benefits over any unit on the market for hard tissue; we have breakthrough technology for soft tissue; and we will have the most affordable price! We think this is what a lot of dentists have been waiting for."
American Medical Technologies expects to take orders for the CaviLase(TM) at the annual meeting of the American Dental Association in Kansas City, beginning October 13th; and shipments are expected to begin in November.
